Clinical Trials Browser

Phase 1/2 × NSCLC × Clear all

NCT05636267 2026-03-09

Study of AK119 and AK112 With or Without Chemotherapy for NSCLC Patients

Phase 1/2 Terminated

NSCLC

NCT04820023 2025-06-06

Phase 1/2 Study of BBT-176 in Advanced NSCLC With Progression After EGFR TKI Treatment

Phase 1/2 Terminated

45 enrolled 19 charts

NSCLC

NCT06940401 2025-05-14

JS111 in Patients With Advanced NSCLC Harboring EGFR Mutations

Phase 1/2 Recruiting

NSCLC

NCT05994131 2025-04-30

IN10018 Combination Therapy in Advanced EGFR Mutation-positive NSCLC

Phase 1/2 Recruiting

NSCLC

NCT05383898 2024-10-15

Study to Evaluate D-1553 in Subjects With Lung Cancer

Phase 1/2 Completed

NSCLC

NCT05492045 2024-10-15

A Study to Evaluate D-1553 in Combination Therapy in Non-Small Cell Lung Cancer

Phase 1/2 Terminated

NSCLC

NCT04402008 2024-06-25

Study of Poziotinib in Japanese Patients With NSCLC

Phase 1/2 Terminated

42 enrolled 16 charts

NSCLC

NCT05332574 2022-08-05

A Safety, Tolerability, PK and Preliminary Activity Study of GB263T in Advanced NSCLC and Other Solid Tumor

Phase 1/2 Unknown

Other solid neoplasmThoracic

NSCLC

NCT03562871 2022-04-21

IO102 With Pembrolizumab, With or Without Chemotherapy, as First-line Treatment of Metastatic NSCLC

Phase 1/2 Completed

NSCLC

NCT04199559 2019-12-16

Evaluating Combination Therapy Using Autologous Dendritic Cells Pulsed With Antigen Peptides and Nivolumab for Subjects With Advanced Non-Small Cell Lung Cancer

Phase 1/2 Unknown

NSCLC

NCT01861223 2014-02-25

Afatinib Plus Nimotuzumb for NSCLC

Phase 1/2 Unknown

NSCLC

NCT00072618 2011-10-20

Phase II Study of Taxotere in Combination With Exisulind in Non-Small Cell Lung Cancer (NSCLC) Patients

Phase 1/2 Completed

NSCLC